Skip to Main Content

Paper Details

TRK inhibitor in a patient with metastatic triple-negative breast cancer and <i>NTRK</i> fusions identified <i>via</i> cell-free DNA analysis.
Ther Adv Med Oncol
2
2023
Author NameAffiliation
Jochen K LennerzMassachusetts General Hospital Cancer Center
Jochen K LennerzHarvard Medical School
Aditya BardiaMassachusetts General Hospital Cancer Center
Aditya BardiaHarvard Medical School
  • 1 - 4

Datasets

Release 1.2